The AstraZeneca COVID-19 vaccine is 97 percent effective against the India strain of the coronavirus.

In a report from Birmingham Mail, a research on nearly 3,300 people in India discovered only two hospitalization with COVID.
All the participants were administered with the AstraZeneca jab and worked in healthcare, the report added.
A study from the Indraprastha Apollo Hospital in New Delhi showed that the risk of being hospitalized with the strain was just 0.06 percent.
"Our study demonstrated that 97.38 percent of those vaccinated were protected from an infection and hospitalization rate was only 0.06 percent," said Dr Anupam Sibal, group medical director.
The results of the study also showed that break-through infections occur only in a small percentage and that these are primarily minor infections that do not lead to severe disease.
"There were no ICU admissions or death. Our study makes the case for vaccination stronger," Sibal added.
UK Health Secretary Matt Hancock had earlier warned that there is a "high degree of confidence" that vaccines can protect individuals against the Indian variant but it can spread like "wildfire" among unvaccinated people.
On April 8, the Philippine government temporarily suspended the use of AstraZeneca vaccines following reports of blood clotting in some recipients abroad.
The use of AstraZeneca vaccines was later resumed after the health department found no present known risk for blood clots after getting the jab.
On May 8, more than two million doses of AstraZeneca vaccines were delivered to the Philippines, bringing the total supply to 7.5 million doses.